Using impedancemetry to monitor hydration and sodium levels in patients with subarachnoid hemorrhage
Interest of Impedancemetry in Monitoring Hydration and Hyponatremia During Subarachnoid Hemorrhages
This study is testing if a new method to check hydration and sodium levels can help improve recovery for adults who have had a serious type of stroke called subarachnoid hemorrhage.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon, France) |
| Trial ID | NCT06646484 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have experienced a subarachnoid hemorrhage (SAH), a serious type of stroke. It aims to evaluate the effectiveness of impedancemetry, a technique that measures water volumes and sodium levels, in managing hydration and preventing complications like delayed cerebral ischemia. By monitoring these parameters, the study seeks to improve patient outcomes in the neurological intensive care unit. Participants will be adults hospitalized within 72 hours of their SAH diagnosis and will be monitored for their hydration status and sodium balance.
Who should consider this trial
Good fit: Ideal candidates are adults hospitalized for subarachnoid hemorrhage within 72 hours of the event.
Not a fit: Patients under legal protection or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the management of hydration and sodium levels in SAH patients, potentially reducing complications and improving recovery.
How similar studies have performed: While the use of impedancemetry in this specific context is novel, similar approaches in monitoring hydration and sodium levels have shown promise in other medical settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult man, woman * Hospitalized following Subarachnoid Hemorrhage within 72 hours of bleeding * Admitted to the neurological intensive care unit for less than 48 hours * Being able to understand the ins and outs of the study * Having expressed his non-opposition Exclusion Criteria: * Patients under legal protection * Pregnancy
Where this trial is running
Lyon, France
- Hospices Civils de Lyon. Neurological ICU — Lyon, France, France (Recruiting)
Study contacts
- Study coordinator: Thomas RITZENTHALER, MD
- Email: Thomas.ritzenthaler@chu-lyon.fr
- Phone: 04.72.11.66.02
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.